ADVFN US – Market Content Editor
-
Five key themes for markets in the week ahead
Geopolitics is taking centre stage at the start of the trading week, with a planned U.S. blockade of the Strait of Hormuz driving fresh volatility across markets. The move has pushed oil prices higher again, while upcoming inflation data and a busy earnings calendar could provide further direction for investors. 1. U.S. moves ahead with…
-
McDonald’s plans energy drinks and new sodas for U.S. menu overhaul – WSJ
McDonald’s (NYSE:MCD) is preparing to expand its beverage lineup in the U.S. with the launch of energy drinks and new flavoured sodas, as part of a broader effort to refresh its cold drink offering, according to a report by The Wall Street Journal. The company is expected to introduce several new drinks in the coming…
-
Meta develops AI version of Zuckerberg to engage with staff – FT
Meta Platforms (NASDAQ:META) is building an artificial intelligence-powered replica of its chief executive Mark Zuckerberg to interact with employees on his behalf, according to a report by the Financial Times citing sources familiar with the project. The company has been advancing photorealistic, AI-driven 3D avatars capable of real-time interaction, and has recently shifted focus toward…
-
Baker Hughes agrees $1.45bn sale of Waygate unit to Hexagon
Baker Hughes (NASDAQ:BKR) said Monday it has reached an agreement to divest its Waygate Technologies division to Swedish group Hexagon AB for $1.45 billion in cash. The disposal forms part of a wider strategic reshaping at Baker Hughes, as the company looks to streamline its portfolio and strengthen its balance sheet and liquidity position. Earlier…
-
Replimune plunges after second FDA setback for melanoma therapy; analysts turn bearish
Shares of Replimune Group (NASDAQ:REPL) tumbled sharply in premarket trading on Monday, falling close to 60% after the U.S. Food and Drug Administration issued a second complete response letter (CRL) for RP1, its oncolytic virus treatment being developed in combination with nivolumab for advanced melanoma. The stock was down more than 57% by 05:10 ET…
-
Oil jumps above $100, dollar strengthens and equities retreat as U.S. targets Iran shipping
Oil prices surged on Monday after the United States moved to enforce a blockade on Iranian-linked shipping following the breakdown of weekend peace negotiations, while the dollar strengthened and both equities and bonds came under pressure. The U.S. action, intended to increase pressure on Tehran, has left a fragile ceasefire in jeopardy and prolonged uncertainty…
-
Gold declines as dollar strengthens on Iran tensions and inflation data
Gold prices moved lower on Monday, pressured by a firmer U.S. dollar as ceasefire discussions between Washington and Tehran failed to produce a breakthrough, prompting investors to seek safety in the greenback. The metal also faced headwinds from stronger-than-expected U.S. inflation data released on Friday, which reduced expectations for near-term interest rate cuts by the…
-
Markets edge lower as Hormuz blockade fears grow; Goldman Sachs earnings in focus: Dow Jones, S&P, Nasdaq, Wall Street Futures
Futures tied to major U.S. equity indices pointed slightly lower at the start of the week, as concerns over a potential U.S. naval blockade of the Strait of Hormuz and stalled negotiations between Washington and Tehran weighed on investor sentiment. Oil prices moved back above $100 per barrel, with markets increasingly uneasy about the durability…
-
Energy stocks rally worldwide as oil tops $100 amid renewed Hormuz concerns
Global oil and gas equities moved higher on Monday as crude prices climbed back above $100 per barrel, following U.S. action to restrict maritime flows linked to Iran through the Strait of Hormuz after negotiations between Washington and Tehran broke down. Brent crude rose 7.3% to $102.16 per barrel by 08:35 GMT, while U.S. benchmark…
-
JPMorgan expects equity support as macro hedge funds rebuild positions
JPMorgan believes equity markets could receive a short-term lift as macro hedge funds move to rebuild stock exposure following the sharp market retreat seen in March, with large U.S. technology companies likely to benefit the most. In a note to clients, analyst Nikolaos Panigirtzoglou said macro hedge funds sharply reduced their equity beta during March,…